These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23098258)

  • 1. Empirical use of fluoroquinolones improves the survival of critically ill patients with tuberculosis mimicking severe pneumonia.
    Tseng YT; Chuang YC; Shu CC; Hung CC; Hsu CF; Wang JY
    Crit Care; 2012 Oct; 16(5):R207. PubMed ID: 23098258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions.
    Shen GH; Tsao TC; Kao SJ; Lee JJ; Chen YH; Hsieh WC; Hsu GJ; Hsu YT; Huang CT; Lau YJ; Tsao SM; Hsueh PR
    Int J Antimicrob Agents; 2012 Mar; 39(3):201-5. PubMed ID: 22285045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-acquired pneumonia and tuberculosis: differential diagnosis and the use of fluoroquinolones.
    Grossman RF; Hsueh PR; Gillespie SH; Blasi F
    Int J Infect Dis; 2014 Jan; 18():14-21. PubMed ID: 24211230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Fluoroquinolone Exposure Prior to Tuberculosis Diagnosis on Clinical Outcomes in Immunocompromised Patients.
    Lee JY; Lee HJ; Kim YK; Yu S; Jung J; Chong YP; Lee SO; Choi SH; Shim TS; Kim YS; Woo JH; Kim SH
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4005-12. PubMed ID: 27090178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of fluoroquinolone use in the respiratory intensive care unit on the development of hospital-acquired MRSA infection and its prognosis].
    Dirican N; Oz AT; Pullukçu H; Aydemir S; Bacakoğlu F
    Mikrobiyol Bul; 2014 Jan; 48(1):28-39. PubMed ID: 24506713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does radiographic evidence of prior pulmonary tubercular infection influence the choice of empiric antibiotics for community-acquired pneumonia in a tuberculosis-endemic area?
    Jeng YY; Lin YT; Huang LJ; Chen TL; Wang FD; Fung CP; Liu CY
    J Microbiol Immunol Infect; 2010 Oct; 43(5):386-94. PubMed ID: 21075705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas.
    Wang JY; Hsueh PR; Jan IS; Lee LN; Liaw YS; Yang PC; Luh KT
    Thorax; 2006 Oct; 61(10):903-8. PubMed ID: 16809417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone exposure prior to tuberculosis diagnosis is associated with an increased risk of death.
    van der Heijden YF; Maruri F; Blackman A; Holt E; Warkentin JV; Shepherd BE; Sterling TR
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1162-7. PubMed ID: 22794509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units.
    Lu Z; Cheng Y; Tu X; Chen L; Chen H; Yang J; Wang J; Zhang L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1867-72. PubMed ID: 27563239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study.
    Lee MR; Lee CH; Wang JY; Lee SW; Ko JC; Lee LN
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):367-376. PubMed ID: 31262613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival in patients with severe tuberculosis after exposure to fluoroquinolones.
    Chiang SR; Shieh JM; Chen CH; Hsing SC; Wen SF; Wang JJ; Cheng KC; Chuang YC
    Infect Dis (Lond); 2016; 48(11-12):789-95. PubMed ID: 27329552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of prior pulmonary tuberculosis in treatment outcomes of HCAP and CAP patients in intensive care units.
    Lin FM; Feng JY; Fang WF; Wu CL; Yu CJ; Lin MC; Ku SC; Chen CW; Tu CY; Yang KY
    J Microbiol Immunol Infect; 2019 Apr; 52(2):320-328. PubMed ID: 30245205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effects of gemifloxacin on the delay of tuberculosis treatment.
    Kim SY; Yim JJ; Park JS; Park SS; Heo EY; Lee CH; Chung HS; Kim DK
    J Korean Med Sci; 2013 Mar; 28(3):378-82. PubMed ID: 23486643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia.
    Martin-Loeches I; Lisboa T; Rodriguez A; Putensen C; Annane D; Garnacho-Montero J; Restrepo MI; Rello J
    Intensive Care Med; 2010 Apr; 36(4):612-20. PubMed ID: 19953222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the delay in diagnosis of pulmonary tuberculosis related to exposure to fluoroquinolones or any antibiotic?
    Wang M; Fitzgerald JM; Richardson K; Marra CA; Cook VJ; Hajek J; Elwood RK; Bowie WR; Marra F
    Int J Tuberc Lung Dis; 2011 Aug; 15(8):1062-8. PubMed ID: 21740669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the fluoroquinolone combination necessary for empirical antibiotic regimen in severe community-acquired pneumonia?
    Oh S; Jang W; Kim B
    Postgrad Med; 2024 Apr; 136(3):337-345. PubMed ID: 38658366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-Onset Bacteremia in Comparison with Third-Generation-Cephalosporin Therapy.
    Lee CC; Wang JL; Lee CH; Hsieh CC; Hung YP; Hong MY; Tang HJ; Ko WC
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia.
    Belforti RK; Lagu T; Haessler S; Lindenauer PK; Pekow PS; Priya A; Zilberberg MD; Skiest D; Higgins TL; Stefan MS; Rothberg MB
    Clin Infect Dis; 2016 Jul; 63(1):1-9. PubMed ID: 27048748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Treatment Failure Following De-escalation to a Fluoroquinolone in Culture-Negative Nosocomial Pneumonia.
    Bultas AC; Bery AI; Deal EN; Hartmann AP; Richter SK; Call WB
    Ann Pharmacother; 2019 Dec; 53(12):1207-1213. PubMed ID: 31347400
    [No Abstract]   [Full Text] [Related]  

  • 20. PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.
    Rello J; Rodriguez A; Lisboa T; Gallego M; Lujan M; Wunderink R
    Crit Care Med; 2009 Feb; 37(2):456-62. PubMed ID: 19114916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.